Clinicopathological features in ovine AA amyloidosis.

Res Vet Sci

Department of Animal Pathology, University of Zaragoza, Veterinary Faculty, Miguel Servet 177, 50013 Zaragoza, Spain.

Published: December 2003

This paper describes the clinicopathological findings in sheep with AA amyloidosis. Serum samples from 12 AA amyloid-affected sheep and urine samples from 5 of these ewes were analyzed. In sera, the most important alteration was reflected in hypoalbuminemia, high concentration in beta and gamma-globulins and high levels of serum BUN, phosphorous and potassium. Serum creatinine, cholesterol and calcium concentrations showed no alterations. Urinary analysis showed proteinuria and a high protein/creatinine ratio. In three urine samples, high activities of urinary enzymes gamma-glutamyl transferase (GGT), beta-glucuronidase (GRS) and N-acetyl-beta-D-glucosaminidase (NAG) were observed, their ratios with urinary creatinine being increased for GGT and NAG and decreased for GRS. In conclusion, important alterations in biochemical and urinary parameters were observed in ovine affected by systemic AA amyloidosis. Those related to the activities of urinary enzymes could constitute reliable parameters for assessing renal injury in ovine AA amyloidosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0034-5288(03)00139-5DOI Listing

Publication Analysis

Top Keywords

ovine amyloidosis
8
urine samples
8
activities urinary
8
urinary enzymes
8
urinary
5
clinicopathological features
4
features ovine
4
amyloidosis
4
amyloidosis paper
4
paper describes
4

Similar Publications

Beta-Amyloid Related Neurodegenerative and Neurovascular Diseases: Potential Implications for Transfusion Medicine.

Transfus Med Rev

October 2024

Calgary Stroke Program, Department of Clinical Neurosciences, Calgary, Alberta, Canada; Hotchkiss Brain Institute, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Article Synopsis
  • Cerebral amyloid angiopathy (CAA) is a brain disorder caused by the accumulation of beta-amyloid in small blood vessels, leading to increased risk of bleeding in the brain and associated neurocognitive decline.
  • It often appears with age, frequently coexists with Alzheimer's Disease, and can result in significant health issues like spontaneous intracerebral hemorrhage and progressive dementia.
  • Recent studies suggest a potential link between blood transfusions and the transmission of CAA, raising concerns about public health and the need for further research on whether CAA can be transmitted through blood, alongside its implications for screening practices.
View Article and Find Full Text PDF

Aesop's fable of the wolf in sheep's clothing encourages us to look beneath the exterior appearance of a situation and evaluate the truth that lies beneath. This concept should be applied when managing older patients with severe aortic stenosis. This population of patients is increasingly being identified as having concomitant cardiac amyloidosis, which is an underrecognized cause of common cardiac conditions.

View Article and Find Full Text PDF

Human islet amyloid polypeptide (hIAPP) plays a role in glucose regulation but forms pancreatic amyloid deposits in type 2 diabetes, and that process contributes to β-cell dysfunction. Not all species develop diabetes, and not all secrete an IAPP that is amyloidogenic under normal conditions, a perfect correlation currently exists between both. Studies of IAPPs from such organisms can provide clues about the high amyloidogenicity of hIAPP and can inform the design of soluble analogues of hIAPP.

View Article and Find Full Text PDF

Amyloid aggregation, including aggregation and propagation of prion protein, is a key factor in numerous human diseases, so-called amyloidosis, with a very poor ability for treatment or prevention. The present work describes the effect of sulfated or sulfonated polymers (sodium dextran sulfate, polystyrene sulfonate, polyanethole sulfonate, and polyvinyl sulfate) on different stages of amyloidogenic conversion and aggregation of the prion protein, which is associated with prionopathies in humans and animals. All tested polymers turned out to induce amyloid conversion of the ovine prion protein.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!